GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Tabula Rasa HealthCare Inc (NAS:TRHC) » Definitions » Cost of Goods Sold

Tabula Rasa HealthCare (Tabula Rasa HealthCare) Cost of Goods Sold : $258.3 Mil (TTM As of Jun. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Tabula Rasa HealthCare Cost of Goods Sold?

Tabula Rasa HealthCare's cost of goods sold for the three months ended in Jun. 2023 was $67.5 Mil. Its cost of goods sold for the trailing twelve months (TTM) ended in Jun. 2023 was $258.3 Mil.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Tabula Rasa HealthCare's Gross Margin % for the three months ended in Jun. 2023 was 25.02%.

Cost of Goods Sold is also directly linked to Inventory Turnover. Tabula Rasa HealthCare's Inventory Turnover for the three months ended in Jun. 2023 was 8.41.


Tabula Rasa HealthCare Cost of Goods Sold Historical Data

The historical data trend for Tabula Rasa HealthCare's Cost of Goods Sold can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tabula Rasa HealthCare Cost of Goods Sold Chart

Tabula Rasa HealthCare Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cost of Goods Sold
Get a 7-Day Free Trial Premium Member Only Premium Member Only 137.67 181.36 160.62 193.38 232.60

Tabula Rasa HealthCare Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Cost of Goods Sold Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 56.63 60.24 63.02 67.52 67.51

Tabula Rasa HealthCare Cost of Goods Sold Calculation

Cost of Goods Sold is the aggregate cost of goods produced and sold, and services rendered during the reporting period. It excludes Total Operating Expense, such as Depreciation, Depletion and Amortization and Selling, General, & Admin. Expense.

Cost of Goods Sold for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $258.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tabula Rasa HealthCare  (NAS:TRHC) Cost of Goods Sold Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Tabula Rasa HealthCare's Gross Margin % for the three months ended in Jun. 2023 is calculated as:

Gross Margin %=(Revenue - Cost of Goods Sold) / Revenue
=(90.036 - 67.507) / 90.036
=25.02 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Cost of Goods Sold is also directly linked to another concept called Inventory Turnover:

Tabula Rasa HealthCare's Inventory Turnover for the three months ended in Jun. 2023 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher inventory turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate inventory turnover. An average inventory is a better indication.


Tabula Rasa HealthCare Cost of Goods Sold Related Terms

Thank you for viewing the detailed overview of Tabula Rasa HealthCare's Cost of Goods Sold provided by GuruFocus.com. Please click on the following links to see related term pages.


Tabula Rasa HealthCare (Tabula Rasa HealthCare) Business Description

Traded in Other Exchanges
N/A
Address
228 Strawbridge Drive, Suite 100, Moorestown, NJ, USA, 08057
Tabula Rasa HealthCare Inc is engaged in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. The cloud-based software solutions of the company help prescribers, pharmacists, and healthcare organizations in managing the medication-related needs of patients. The firm operates the business through two segments namely CareVention HealthCare and MedWise HealthCare.
Executives
Michael Anthony Bruno officer: CHIEF ACCOUNTING OFFICER 1504 PEAR TREE LANE, BENSALEM PA 19020
Derek C Schrier director, 10 percent owner C/O INDABA CAPITAL MANAGEMENT, LLC, ONE LETTERMAN DR., BLDING D, SUITE DM700, SAN FRANCISCO CA 94129
Indaba Capital Fund, L.p. director, 10 percent owner MAPLES CORPORATE SERVICES, 121 SOUTH CHURCH STREET, GRAND CAYMAN E9 KY1-1104
Indaba Capital Management, L.p. director, 10 percent owner ONE LETTERMAN DRIVE, BUILDING D, SUITE DM700, SAN FRANCISCO CA 94129
Ic Gp, Llc director, 10 percent owner ONE LETTERMAN DRIVE,, BUILDING D, SUITE DM700, SAN FRANCISCO CA 94129
Rew Richard W. Ii officer: Chief Legal Officer, Secretary 7000 WEST WILLIAM CANNON, BUILDING ONE, AUSTIN TX 78735
Thomas Cancro officer: CHIEF FINANCIAL OFFICER C/O GFI GROUP INC., NEW YORK NY 10041
Michael J. Purcell director C/O PATRIOT NATIONAL, INC., 401 E. LAS OLAS BLVD., SUITE 1650, FORT LAUDERDALE FL 33301
Ronald Paul Mitchell director 110 W. KINZIE STREET, 5TH FL, CHICAGO IL 60654
Jonathan David Schwartz director 430 EAST 29TH STREET, SUITE 1040, NEW YORK NY 10016
Dennis Helling director 228 STRAWBRIDGE DRIVE, SUITE 100, MOORESTOWN NJ 08057
Michael Greenhalgh officer: Chief Operating Officer 228 STRAWBRIDGE DRIVE, SUITE 100, MOORESTOWN NJ 08057
Gordon Tunstall director
Andrea Carolan Speers officer: Chief Accounting Officer 228 STRAWBRIDGE DRIVE, SUITE 100, MOORESTOWN NJ 08057
Brian W Adams officer: Chief Financial Officer 228 STRAWBRIDGE DRIVE, SUITE 100, MOORESTOWN NJ 08057